Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$30.95
+3.8%		$32.35
$13.74
▼
$65.30
$7.23B2.425.77 million shs4.34 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,184.12
-0.4%		$1,186.29
$712.05
▼
$1,292.65
$1.11T0.513.08 million shs968,714 shs
Meta Platforms, Inc. stock logo
META
Meta Platforms
$570.75
-0.9%		$592.39
$520.26
▼
$790.80
$1.46T1.2516.79 million shs8.75 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.07
-2.4%		$47.92
$35.12
▼
$64.16
$205.60B0.7617.63 million shs7.37 million shs
Snap Inc. stock logo
SNAP
Snap
$5.51
+1.6%		$4.88
$3.81
▼
$9.28
$9.31B1.0347.82 million shs17.01 million shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-5.85%-3.74%-1.18%+17.59%-34.36%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-3.29%-6.96%-0.53%+5.75%+62.12%
Meta Platforms, Inc. stock logo
META
Meta Platforms
+1.07%+5.51%-2.99%-9.31%-23.60%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-2.91%+1.79%-4.83%+3.78%-14.57%
Snap Inc. stock logo
SNAP
Snap
-8.69%+3.24%+19.56%-8.38%-22.99%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$30.95
+3.8%		$32.35
$13.74
▼
$65.30
$7.23B2.425.77 million shs4.34 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,184.12
-0.4%		$1,186.29
$712.05
▼
$1,292.65
$1.11T0.513.08 million shs968,714 shs
Meta Platforms, Inc. stock logo
META
Meta Platforms
$570.75
-0.9%		$592.39
$520.26
▼
$790.80
$1.46T1.2516.79 million shs8.75 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.07
-2.4%		$47.92
$35.12
▼
$64.16
$205.60B0.7617.63 million shs7.37 million shs
Snap Inc. stock logo
SNAP
Snap
$5.51
+1.6%		$4.88
$3.81
▼
$9.28
$9.31B1.0347.82 million shs17.01 million shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-5.85%-3.74%-1.18%+17.59%-34.36%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-3.29%-6.96%-0.53%+5.75%+62.12%
Meta Platforms, Inc. stock logo
META
Meta Platforms
+1.07%+5.51%-2.99%-9.31%-23.60%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-2.91%+1.79%-4.83%+3.78%-14.57%
Snap Inc. stock logo
SNAP
Snap
-8.69%+3.24%+19.56%-8.38%-22.99%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.19
Hold$32.505.01% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.83
Moderate Buy$1,292.189.13% Upside
Meta Platforms, Inc. stock logo
META
Meta Platforms
2.89
Moderate Buy$785.2237.58% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.16
Hold$64.9440.97% Upside
Snap Inc. stock logo
SNAP
Snap
2.25
Hold$7.6538.93% Upside

Current Analyst Ratings Breakdown

Latest HIMS, NVO, LLY, META, and SNAP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Sell
8/27/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$770.00 ➝ $763.00
8/27/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold
8/27/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
Rosenblatt Securities logo
Rosenblatt Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$883.00 ➝ $886.00
8/27/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold
8/24/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$27.00 ➝ $32.00
8/21/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$39.00 ➝ $35.00
8/12/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Berenberg Bank logo
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$47.00
8/12/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Berenberg Bank logo
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
8/11/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B) ➝ Buy (B-)
8/11/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$25.00 ➝ $26.00
(Data available from 8/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.58B2.80$0.82 per share37.94$1.39 per share22.27
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B17.10$24.13 per share49.08$35.99 per share32.90
Meta Platforms, Inc. stock logo
META
Meta Platforms
$200.97B7.23$37.60 per share15.18$102.54 per share5.57
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$329.43B0.62$4.44 per share10.38$6.58 per share7.00
Snap Inc. stock logo
SNAP
Snap
$6.35B1.47N/AN/A$1.14 per share4.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.63N/A61.90N/A-5.51%-6.51%-1.20%11/9/2026 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$29.8039.7325.811.4633.53%97.83%23.23%10/29/2026 (Estimated)
Meta Platforms, Inc. stock logo
META
Meta Platforms
$60.46B$26.5521.5316.560.9729.83%33.18%20.07%10/28/2026 (Estimated)
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$4.0911.2613.674.4035.36%61.20%21.49%11/4/2026 (Estimated)
Snap Inc. stock logo
SNAP
Snap
-$460.49M-$0.18N/A110.10N/A-4.90%-14.61%-4.12%10/15/2026 (Estimated)

Latest HIMS, NVO, LLY, META, and SNAP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$0.0498-$0.37-$0.3202-$0.37$698.90 million$753.21 million
8/5/2026Q2 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.40$8.38+$1.98$7.94$20.82 billion$22.97 billion
8/5/2026Q2 2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.77$0.96+$0.19$0.72$10.89 billion$11.98 billion
8/3/2026Q2 2026
Snap Inc. stock logo
SNAP
Snap
-$0.1218-$0.10+$0.0218-$0.10$1.54 billion$1.60 billion
7/29/2026Q2 2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$7.19$6.18-$1.01$6.18$60.22 billion$60.80 billion
6/30/2026Q2 2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
N/A$0.9440N/A$0.72N/A$11.98 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.58%+15.18%23.22%11 Years
Meta Platforms, Inc. stock logo
META
Meta Platforms
$2.100.37%N/A7.91%1 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.811.76%+21.74%19.80%N/A
Snap Inc. stock logo
SNAP
Snap
N/AN/AN/AN/AN/A

Latest HIMS, NVO, LLY, META, and SNAP Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/22/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.59%8/14/20268/14/20269/10/2026
8/5/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.57862.58%8/17/20268/17/20268/25/2026
5/28/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
quarterly$0.52500.35%6/15/20266/15/20266/25/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
4.21
0.93
0.87
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.41
1.35
1.00
Meta Platforms, Inc. stock logo
META
Meta Platforms
0.32
2.23
2.23
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.59
0.79
0.56
Snap Inc. stock logo
SNAP
Snap
1.75
2.94
2.94

Institutional Ownership

CompanyInstitutional Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Meta Platforms, Inc. stock logo
META
Meta Platforms
79.91%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%
Snap Inc. stock logo
SNAP
Snap
47.52%

Insider Ownership

CompanyInsider Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
Meta Platforms, Inc. stock logo
META
Meta Platforms
13.53%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
Snap Inc. stock logo
SNAP
Snap
22.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442233.31 million205.88 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000941.36 million940.04 millionOptionable
Meta Platforms, Inc. stock logo
META
Meta Platforms
78,8652.55 billion2.20 billionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable
Snap Inc. stock logo
SNAP
Snap
5,2611.69 billion1.31 billionOptionable

Recent News About These Companies

Zacks Research Comments on Snap's Q3 Earnings (NYSE:SNAP)
August 27 at 6:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-zacks-research-comments-on-snaps-q3-earnings-nyse-snap-2026-08-27/
Youth Engagement Lawsuit Could Be A Game Changer For Snap’s (SNAP) Core Monetization Model
August 27 at 1:24 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/youth-engagement-lawsuit-could-game-021304359.html
Does Snap (SNAP) Need A Saudi Communications Chief To Grow Its Middle East Story?
August 26 at 8:24 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/does-snap-snap-saudi-communications-210843754.html
Snap (NYSE:SNAP) Stock Price Down 6.6% - Here's Why
August 26 at 11:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-snap-nyse-snap-stock-price-down-66-heres-why-2026-08-26/
Snap Sinks 7% as Pennsylvania Sues Snapchat, Meta Holds Flat After a $16.7B Settlement
August 26 at 10:11 AM  |  247wallst.comhttps://247wallst.com/investing/2026/08/26/snap-sinks-7-as-pennsylvania-sues-snapchat-meta-holds-flat-after-a-16-7b-settlement/?utm_source=snapi
Investors Purchase High Volume of Snap Call Options (NYSE:SNAP)
August 25 at 4:59 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/options-investors-purchase-high-volume-of-snap-call-options-nyse-snap-2026-08-25/
Snap Inc. (NYSE:SNAP) Receives Consensus Recommendation of "Hold" from Analysts
August 24 at 2:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/snap-inc-nysesnap-receives-consensus-recommendation-of-hold-from-analysts-2026-08-24/
Insider Selling: Snap (NYSE:SNAP) CAO Sells $90,147.20 in Stock
August 20, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nyse-snap-insider-buying-and-selling-2026-08-20/
Snap's CFO Sells Nearly 132,000 Shares. Here's What That Means for Investors.
August 20, 2026  |  fool.comhttps://www.fool.com/coverage/filings/2026/08/20/snap-s-cfo-sells-nearly-132-000-shares-here-s-what-that-means-for-investors/
Snap (NYSE:SNAP) CAO Sells 17,336 Shares
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/snap-nysesnap-cao-sells-17336-shares-2026-08-19/
Snap (NYSE:SNAP) Insider Ajit Mohan Sells 54,608 Shares
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/snap-nysesnap-insider-ajit-mohan-sells-54608-shares-2026-08-19/
Snap (NYSE:SNAP) General Counsel Zachary Briers Sells 136,504 Shares
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/snap-nysesnap-general-counsel-zachary-briers-sells-136504-shares-2026-08-19/
Snap (NYSE:SNAP) General Counsel Sells 67,540 Shares of Stock
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/snap-nysesnap-general-counsel-sells-67540-shares-of-stock-2026-08-19/
Snap (NYSE:SNAP) CFO Douglas Hott Sells 131,884 Shares of Stock
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/snap-nysesnap-cfo-douglas-hott-sells-131884-shares-of-stock-2026-08-19/
Snap (NYSE:SNAP) Sees Unusually-High Trading Volume - What's Next?
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/snap-nysesnap-sees-unusually-high-trading-volume-whats-next-2026-08-17/
What's driving Snap stock lower on Monday?
August 17, 2026  |  invezz.comI
Snap Stock Drops Monday: What's Driving the Move?
August 17, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/26/08/61245763/snap-stock-drops-monday-whats-driving-the-move?utm_source=snapi
Snap shares tumble as court ruling and insider selling deepen investor concerns
August 17, 2026  |  investorshub.advfn.comhttps://investorshub.advfn.com/market-news/article/34369/snap-shares-tumble-as-court-ruling-and-insider-selling-deepen-investor-concerns
Quantinno Capital Management LP Has $2.11 Million Stake in Snap Inc. $SNAP
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantinno-capital-management-lp-has-211-million-stake-in-snap-inc-snap-2026-08-11/
Assenagon Asset Management S.A. Has $17.33 Million Stock Holdings in Snap Inc. $SNAP
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-assenagon-asset-management-sa-has-1733-million-stock-holdings-in-snap-inc-snap-2026-08-11/
Rocket Lab Stock Set to Snap Win Streak Before Earnings
August 10, 2026  |  schaeffersresearch.comhttps://www.schaeffersresearch.com/content/analysis/2026/08/10/rocket-lab-stock-set-to-snap-win-streak-before-earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
The Metals Company logo displayed over an image of polymetallic nodules on the seafloor with sea stars.
The Metals Company’s Big Bet Now Comes Down to a License
By Thomas Hughes | August 16, 2026
NVIDIA logo displayed on a computer chip surrounded by illuminated green circuit board traces.
NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
By Thomas Hughes | August 11, 2026
Laptop displaying stock price and bar charts on a desk, surrounded by icons representing tech, banking, healthcare, and retail sectors.
The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
By Jessica Mitacek | August 3, 2026
Trading floor with digital stock displays and workstations, overlaid with the text "S&P 500".
5 Reasons the S&P 500 Could Keep Rallying Through Year-End
By Thomas Hughes | August 20, 2026
Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$30.95 +1.12 (+3.75%)
As of 01:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,184.12 -5.29 (-0.44%)
As of 01:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Meta Platforms stock logo

Meta Platforms NASDAQ:META

$570.75 -5.39 (-0.94%)
As of 01:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$46.06 -1.13 (-2.38%)
As of 01:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Snap stock logo

Snap NYSE:SNAP

$5.50 +0.09 (+1.57%)
As of 01:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Snap Inc. operates as a technology company in North America, Europe, and internationally. The company offers Snapchat, a visual messaging application with various tabs, such as camera, visual messaging, snap map, stories, and spotlight that enable people to communicate visually through short videos and images. It also provides Spectacles, an eyewear product that connects with Snapchat and captures photos and video from a human perspective; and advertising products, including AR ads and Snap ads comprises a single image or video ads, collection ads, dynamic ads, story ads, and commercials. The company was formerly known as Snapchat, Inc. and changed its name to Snap Inc. in September 2016. Snap Inc. was founded in 2010 and is headquartered in Santa Monica, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas